EMR Stock Recent News
EMR LATEST HEADLINES
Emerson (EMR) sells the remaining 40% common equity ownership in Copeland for $3.4 billion to strengthen its position as a global leader in automation.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Investors with an interest in Manufacturing - Electronics stocks have likely encountered both Emerson Electric (EMR) and Franklin Electric (FELE). But which of these two stocks presents investors with the better value opportunity right now?
Emerson Electric (EMR) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Emerson's (EMR) third-quarter fiscal 2024 sales increase 11% year over year, driven by solid segmental performance.
Although the revenue and EPS for Emerson Electric (EMR) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Emerson Electric (EMR) came out with quarterly earnings of $1.43 per share, beating the Zacks Consensus Estimate of $1.42 per share. This compares to earnings of $1.29 per share a year ago.
ST. LOUIS , Aug. 7, 2024 /PRNewswire/ -- Emerson (NYSE: EMR) today reported results1 for its third quarter ended June 30, 2024 and updated its full year outlook for fiscal 2024. Emerson also declared a quarterly cash dividend of $0.525 per share of common stock payable September 10, 2024 to stockholders of record on August 16, 2024.
Emerson Electric's (EMR) Q3 results are likely to benefit from strong demand, solid backlog and contributions from acquisitions. However, high operating expenses are likely to have affected its margins.
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Emerson Electric (EMR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.